Cells (Nov 2022)

RUNX Proteins as Epigenetic Modulators in Cancer

  • Hongyang Yi,
  • Yuhao He,
  • Qionghua Zhu,
  • Liang Fang

DOI
https://doi.org/10.3390/cells11223687
Journal volume & issue
Vol. 11, no. 22
p. 3687

Abstract

Read online

RUNX proteins are highly conserved in metazoans and perform critical functions during development. Dysregulation of RUNX proteins through various molecular mechanisms facilitates the development and progression of various cancers, where different RUNX proteins show tumor type-specific functions and regulate different aspects of tumorigenesis by cross-talking with different signaling pathways such as Wnt, TGF-β, and Hippo. Molecularly, they could serve as transcription factors (TFs) to activate their direct target genes or interact with many other TFs to modulate chromatin architecture globally. Here, we review the current knowledge on the functions and regulations of RUNX proteins in different cancer types and highlight their potential role as epigenetic modulators in cancer.

Keywords